Invest now
Sai Life Sciences Balance Sheet Annual
BSE: 544306 | NSE: SAILIFE | ISIN: INE570L01029 | Sector: Biotechnology & Drugs1,455.65 +31.20 (2.19%)Updated : 11 Aug 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 3,626.14 | 3,159.98 | 2,275.14 | 2,186.65 |
| Cash Equivalents | 110.87 | - | - | - |
| Other Liabilities Total | 32.32 | 23.41 | 20.38 | 19.92 |
| Long Term Debt | 20.50 | 0.00 | 277.73 | 261.45 |
| Common Stock Total | 21.18 | 20.84 | 18.05 | 18.01 |
| Other Current Assets Total | 624.11 | 136.00 | 16.71 | 21.26 |
| Total Assets | 3,626.14 | 3,159.98 | 2,275.14 | 2,186.65 |
| Current Portof LT Debt/ Capital Leases | 140.33 | 187.69 | 100.39 | 103.64 |
| Total Equity | 2,483.69 | 2,128.35 | 975.14 | 888.09 |
| Long Term Investments | 3.51 | 1.94 | 1.87 | 1.87 |
| Retained Earnings( Accumulated Deficit) | 2,462.51 | 730.34 | 564.84 | 479.84 |
| Total Common Shares Outstanding | 21.18 | 20.84 | 20.80 | 20.80 |
| Property/ Plant/ Equipment Total- Gross | 270.45 | 2,196.59 | 1,748.71 | 1,542.97 |
| Tangible Book Valueper Share Common Eq | 116.99 | 101.60 | 46.22 | 42.15 |
| Total Liabilities | 1,142.45 | 1,031.62 | 1,299.99 | 1,298.55 |
| Total Debt | 288.45 | 352.38 | 928.14 | 932.85 |
| Short Term Investments | 150.96 | 281.13 | 161.00 | 135.00 |
| Cashand Short Term Investments | 261.83 | 372.25 | 184.66 | 204.91 |
| Total Receivables Net | 373.62 | 842.17 | 629.96 | 574.38 |
| Deferred Income Tax | 128.33 | 111.04 | 86.27 | 62.53 |
| Accounts Receivable- Trade Net | 373.62 | 761.50 | 567.83 | 465.87 |
| Property/ Plant/ Equipment Total- Net | 2,079.17 | 1,601.81 | 1,272.96 | 1,176.49 |
| Total Current Liabilities | 833.68 | 732.49 | 739.90 | 758.85 |
| Total Inventory | 150.97 | 129.26 | 92.57 | 148.32 |
| Accounts Payable | 285.34 | 322.51 | 199.41 | 208.95 |
| Other Currentliabilities Total | 408.01 | 142.76 | 64.15 | 72.92 |
| Total Long Term Debt | 148.12 | 164.69 | 453.45 | 457.25 |
| Intangibles Net | 6.12 | 10.86 | 13.77 | 11.43 |
| Other Long Term Assets Total | 123.58 | 28.46 | 18.28 | 11.72 |
| Note Receivable- Long Term | 3.24 | 12.40 | 23.14 | 21.19 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 1,410.53 | 1,504.51 | 945.11 | 963.95 |
| Capital Lease Obligations | 127.62 | 164.69 | 175.72 | 195.80 |
| Accumulated Depreciation Total | - | -594.78 | -475.75 | -366.49 |
| Accrued Expenses | - | 79.53 | 1.66 | 1.38 |
| Other Equity Total | - | 4.00 | 3.10 | 2.66 |
| Prepaid Expenses | - | 24.82 | 21.21 | 15.08 |
| Additional Paid- In Capital | - | 1,373.17 | 389.16 | 387.58 |
| Cash | - | 91.12 | 23.66 | 69.91 |
| Notes Payable/ Short Term Debt | - | 0.00 | 374.30 | 371.97 |
*All figures in crores except per share values
Sai Life Sciences Quick Links
Sai Life Sciences Dividend Sai Life Sciences Bonus Sai Life Sciences News Sai Life Sciences AGM Sai Life Sciences Rights Sai Life Sciences Splits Sai Life Sciences Board Meetings Sai Life Sciences Key Metrics Sai Life Sciences Shareholdings Sai Life Sciences Profit Loss Sai Life Sciences Cashflow Sai Life Sciences Q1 Results Sai Life Sciences Q2 Results Sai Life Sciences Q3 Results Sai Life Sciences Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
5,098.20+155.20(3.14%)
1,102.85+20.85(1.93%)
2,024.95+23.05(1.15%)
1,072.00-24.05 (-2.19%)
310.50-4.95 (-1.57%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.